Recent News

• 04.16.2025 - Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
• 04.16.2025 - Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
• 04.16.2025 - Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
• 03.26.2025 - Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
• 03.26.2025 - Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
• 03.24.2025 - Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
• 03.24.2025 - Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
• 03.24.2025 - Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
• 02.03.2025 - Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers
• 02.03.2025 - Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers

Recent Filings

• 03.28.2025 - 8-K Current report
• 03.21.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.11.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.11.2025 - 8-K Current report
• 01.21.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 01.17.2025 - 8-K Current report